[Media Releases] LegoChem is selected as the 'K-Brain Power' company (Yonhap News, 24 July 2014)

Title:  LegoChem is selected as the “K-Brain Power” company

Publication: Yonhap News

Date: 24 July 2014

URL: link to website (contents in Korean)

Summary

·         The Ministry of Trade, Industry, and Energy in Korea designated 18 SMEs as “K-Brain Powers”, which refers to top companies that create added value with their business strategies and innovative ideas.

·         LegoChem Biosciences is one of the selected companies.

·         The Ministry also announced its plan to invest $5 million to assist these 'Brain' companies in their research and development, and earmarked an additional $0.6 million for recruitment of talented workforce from abroad.

·         LegoChem Biosciences is a biopharmaceutical company with its own proprietary technologies for new drug development.

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).